Frost, Jonas
Gornicec, Maximilian
Reisinger, Alexander C. http://orcid.org/0000-0002-5773-5695
Eller, Philipp http://orcid.org/0000-0001-5537-3646
Hoenigl, Martin http://orcid.org/0000-0002-1653-2824
Prattes, Juergen http://orcid.org/0000-0001-5751-9311
Funding for this research was provided by:
Medical University of Graz
Article History
Received: 22 May 2023
Accepted: 7 October 2023
First Online: 13 January 2024
Declarations
:
: M.H. received research funding from Gilead, Astellas, MSD, Euroimmune, Scynexis, F2G and Pfizer, outside of the submitted work. J.P. has received speakers’ fees from Gilead Sciences, Pfizer, Swedish Orphan Biovitrum, Associated of Cape Cod, served at advisor boards for Gilead Sciences and Pfizer and holds stocks of Novo Nordisk and AbbVie Inc–all outside of the submitted work.
: The study was approved by the local ethics committee (32–296 ex 19/20).
: According to our local ethics committee regulations, informed consent form was obtained from all patients, whenever possible.
: Not applicable.